Search filters

Filters
Clear All

Phase

  • 59
  • 97
  • 108
  • 89
  • 14
  • 170
  • 696
  • 449
  • 14
  • 31
  • 1
  • 4
  • 648

Found 698 none trials

A listing of none medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

18 years - 70 years
Male
Phase 3
Phase 1 will enroll 10 healthy participants. We will use remote sensors worn on the wrist and waist to collect data on personal exposure to air pollutants and check your physical functioning over approximately 48 hours in this 3 Phase study. This will build an understanding on which types of …
18 years - 70 years
All genders
Phase 2
The main purpose of this study is to see if an experimental drug, TRADIPITANT can help people with diabetic or idiopathic gastroparesis who are suffering from nausea.
 PD GPI MRFGUS
30 years - 100 years
All genders
To demonstrate ExAblate procedure is safe and works.There is evidence in medical literature showing that by ablating a particular cluster of cells in the brain, dyskinesia (abnormal movements)&motor symptoms of PD may improve. ExAblate can be used to perform ablation more precisely in minimally invasive fashion. In this study we …
 Neural and Motor Functional Changes in HIV and Stroke Before and After Robot-Assisted Neurorehabilitation
18 years - 100 years
All genders
The purpose of this research study is twofold: to study the role HIV has on the brain’s function and more particularly, the relationship between HIV and stroke; and to study how the presence of HIV effects robot-assisted rehabilitation after stroke, and its association with clinical improvement.
 ESCAPE Room for Rehabilitation
18 years - 100 years
All genders
This study aims to evaluate user experiences in commercial ESCAPE rooms to determine design opportunities for an ESCAPE room targeted for Rehabilitation after traumatic and non-traumatic brain injury. We will investigate older versus younger as well as healthy versus impaired user experiences in commercial ESCAPE room (survey) and 2) will …
 Evaluation of a Mobile Robot Platform for TeleRehabilitation Flo Prospective Trials
6 years - 70 years
All genders
To extend the geographic reach of clinicians, from urban hospitals to distant clinics, and to increase the objectivity of diagnostics, when applied to pediatric patients with upper extremity impairments, we propose a series of tests to validate the need and methods for the Lil'Flo robotic system. Lil'Flo is comprised of …
 Phase 1 Open-Label Study to Determine the Safety and Tolerability of AVID200, a Transforming Growth Factor B Inhibitor, in Diffuse Cutaneous Systemic Sclerosis
18 years - 90 years
All genders
Phase 1
This study is being done to learn more about the safety of the study drug, AVID200, and to find out more about the effects of different study drug doses in people with scleroderma.  AVID200 is referred to as an investigational drug because it is in the early stages of development …
 Neurobiology of Caregiving in New Mothers (Children between 0-3 years old)
1 years - 42 years
Female
This study is to learn more about social processes on a behavioral and brain level in new mothers. If you are eligible, there are three in person visits, one consisting of an fMRI scan. MRI uses magnetic fields to take pictures of the brain. MRI does not use X-rays and …
 Study to Evaluate the Safety and Efficacy of Upadacitinib in Giant Cell Arteritis: SELECT-GCA
50 years - 100 years
All genders
Phase 3
The main purpose of this study is to understand how well giant cell arteritis (also known as temporal arteritis; GCA) responds to an investigational drug called upadacitinib. Upadacitinib is being tested to find out if it is safe and effective in treating GCA. An investigational drug is one that is …
 A Randomized, Double-Blind, Placebo Controlled Study to Evaluate Efficacy and Safety of Nefecon in Patients with Primary IgA Nephropathy at Risk of Progressing to End-Stage Renal Disease (NefIgArd)
1 years - 100 years
All genders
Phase 3
The research study is being conducted to see how well the investigational drug, Nefecon, works for the treatment of your kidney disease and more specific for patients with "primary immunoglobulin A nephropathy," called IgAN.
61 - 70 of 698